EIF2AK3 and neoplasm: Lastly, we found that cleaved PARP was also increased in tumors treated with both PERK inhibitor and 5-FU (Fig. 4E), further showing the exceptional anti-tumor effects delivered by the combinatory administration with chemotherapeutic agent and PERK inhibitor.